《大行》中金首予赤子城科技(09911.HK)「跑嬴大市」評級 目標價11.3元
中金發表報告,首予赤子城科技(09911.HK)「跑嬴大市」評級,目標價11.3元。
報告指,赤子城科技已推出數十個社交網絡應用程式及休閒遊戲產品,為超過100個國家及地區的10億用戶提供服務。除中東和北非市場,公司亦正在東南亞、歐洲、美國、日本和韓國等地拓展業務,目標是發展成為全球領先的社交娛樂公司。該行預測2025年每股盈利為0.8元人民幣,2026年為1元人民幣,年複合增長率為54%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.